Life insurance companies confirm smoking status through a combination of self‑disclosure, medical examinations, laboratory tests, and third‑party data checks. They compare your answers on the application with objective evidence to assess risk and set premiums.
More from this site
Keep reading the latest coverage
Application questionnaire
Applicants are required to answer a detailed health questionnaire that asks about current tobacco use, recent cessation, and exposure to nicotine products. Misstatements can be considered fraud and lead to policy rescission.
Medical exam and lab analysis
Most standard policies include a physical exam where a technician collects a blood or urine sample. Labs test for cotinine, a nicotine metabolite, which remains detectable for up to 10 days in blood and 3 weeks in urine. Elevated levels confirm recent use.
Electronic health records and prescription data
Insurers may request access to your electronic medical records or pharmacy histories. Prescriptions for nicotine replacement therapy, varenicline, or bupropion can signal recent quitting attempts, while notes about smoking status in physician charts provide additional verification.
Third‑party databases
Companies often subscribe to data services that aggregate public records, credit‑report information, and previous insurer disclosures. These databases can flag known smokers based on prior policies or claims.
Comparative overview
| Method | Detection window | Reliability |
|---|---|---|
| Self‑report questionnaire | Immediate | Low – relies on honesty |
| Cotinine lab test | 10‑21 days | High – objective biomarker |
| Medical record review | Ongoing | Medium – depends on documentation |
| Third‑party data | Varies | Medium – indirect evidence |
Impact on underwriting
If testing shows nicotine use, insurers typically classify the applicant as a smoker, which can raise premiums by 30 % to 100 % or more, depending on age and health. Accurate disclosure avoids future disputes and ensures the policy remains in force.